Assessment of COVID-19 vaccination performance in Tlemcen: Insights into vaccine inventory management | ||
| Microbes and Infectious Diseases | ||
| Articles in Press, Accepted Manuscript, Available Online from 27 January 2025 | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mid.2025.307979.2112 | ||
| Authors | ||
| Ilyes Zatla* 1; Lamia Boublenza1; Wafaa Lemerini2; Dalale Bahar1; Bouchra Dahmani1; Abia Khouani1; Nabahate Selka3 | ||
| 1Laboratory of Microbiology applied to the Food industry, Biomedical and the Environment, Faculty of Natural and Life Sciences, Earth and Universe Sciences. Department of Biology. University of Tlemcen, 13000, Algeria | ||
| 2Laboratory of Organic Chemistry, Natural Substances, and Analysis, Faculty of Natural and Life Sciences, Earth and Universe Sciences. Department of Biology. University of Tlemcen, 13000, Algeria | ||
| 3MD in Epidemiology, Public Health Establishment Near Tlemcen (EPSP), 1300, Algeria | ||
| Abstract | ||
| Background: The global response to the COVID-19 pandemic has been characterized by unprecedented vaccination efforts aimed at mitigating the spread of the virus and curbing its impact on public health. Methods: This study presents a comprehensive analysis of the vaccination campaign in Tlemcen, Algeria, focusing on vaccine distribution, utilization, and demographic trends. Data from the Public Health Establishment near Tlemcen were analyzed using Excel and SPSS to assess the distribution and management of five distinct vaccine brands: Sputnik, AstraZeneca, Sinopharm, Sinovac, and Janssen. Statistical analysis included the calculation of means, standard deviations, and percentages to evaluate vaccine distribution, uptake, and wastage. Results: The findings revealed varying levels of efficiency and challenges in vaccine management across different brands. Specifically, Sinovac had the highest administered doses at 93,908, representing 91.94% of its total imported vaccines. Sputnik had the lowest wastage rate, with no expired vaccines and only 10.35% lost doses. Age-specific trends in vaccine uptake highlighted Sinovac's prominence among the 50-64 and 65+ age groups, while Janssen was more popular in the 30-49 age group. Additionally, individuals with comorbidities showed a higher vaccine response to Sinovac, suggesting the need for tailored vaccination strategies for this subgroup. Conclusion: These findings provide valuable insights into the dynamics of the vaccination campaign in Tlemcen and contribute to ongoing efforts to optimize vaccination strategies and mitigate the impact of COVID-19. | ||
| Keywords | ||
| SARS-CoV-2; Vaccines; Public Health; Algeria | ||
|
Statistics Article View: 85 |
||
